France· FR:69181040
CRESEMBA 100 mg, gélule
A medicinal product containing sulfate d'isavuconazonium, registered in France by BASILEA PHARMACEUTICA DEUTSCHLAND (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE D'ISAVUCONAZONIUM
- Manufacturer
- BASILEA PHARMACEUTICA DEUTSCHLAND (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300399082 plaquette(s) aluminium de 7 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate d'isavuconazonium in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCresembaParanova Oy
- SwitzerlandCresemba
- CzechiaCRESEMBABasilea Pharmaceutica Deutschland GmbH, Lörrach
- IcelandCRESEMBABasilea Pharmaceutica Deutschland GmbH
- NorwayCresembaBasilea Pharmaceutica Deutschland GmbH
- SwedenCRESEMBA 100 mg Kapsel, hårdBasilea Pharmaceutica Deutschland GmbH
- BelgiumCresemba 100 mgBasilea Pharmaceutica Deutschland
- United StatesCRESEMBAAstellas Pharma US, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Cresemba
- Norway · Cresemba
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/475d62d6-9065-46db-a198-3de1c3efa49e GET /v1/drugs/475d62d6-9065-46db-a198-3de1c3efa49e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69181040",
"date_amm": "2015-10-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1036",
"substance": "SULFATE D'ISAVUCONAZONIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate d'isavuconazonium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.